<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01296841</url>
  </required_header>
  <id_info>
    <org_study_id>TELEMED PA</org_study_id>
    <nct_id>NCT01296841</nct_id>
  </id_info>
  <brief_title>Telemedicine To Provide Inflammatory Bowel Disease Outpatient Care</brief_title>
  <official_title>A Randomized Controlled Pilot: Use of Telemedicine To Provide Inflammatory Bowel Disease Outpatient Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Palo Alto Health Care System</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Palo Alto Health Care System</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that outpatient clinical care of Inflammatory Bowel Disease
      patients may be provided using a new computerized system over standard network - called
      Collaborative Imaging - with similar patient experience compared to a conventional clinic
      visit.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Significant advances in gastroenterology have led the field to grow into a number of advanced
      subspecialties: inflammatory bowel disease (IBD), motility, therapeutic endoscopy, and
      transplant hepatology. Telemedicine, the application of information technology in support of
      health care delivery from a distance, has been employed with good success in various chronic
      conditions with excellent patient satisfaction.

      Primary Aim: Our primary study endpoint was measuring patient clinical experience between two
      groups: A telemedicine remote clinic visit and a standard &quot;in-house&quot; visit.

      Secondary Aim: To compare standard clinic metrics including clinic wait time, patient
      throughput, and appointment time between the two groups.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Clinical Experience</measure>
    <time_frame>Clinic Visit</time_frame>
    <description>We used a validated Ware Specific Visit Questionnaire to assess patients' satisfaction with their clinic-visit encounter. This is a 14-item questionnaire on doctor-patient interaction including factors such as attention to complaints, technical skills, and personal manner (courtesy,and ease of appointment scheduling and is based on a five-point Likert scale (1 excellent to 5 poor). Patients completed the questionnaire at the time of the visit. The 14 item scores were individually scored and then averaged to provide the final overall value.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinic Appointment Duration</measure>
    <time_frame>Clinic Visit</time_frame>
    <description>The investigators recorded appointment duration in minutes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinic Appointment Wait Time</measure>
    <time_frame>Clinic Visit</time_frame>
    <description>The investigators recorded clinic appointment wait time duration in minutes</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Inflammatory Bowel Disease</condition>
  <condition>Ulcerative Colitis</condition>
  <condition>Crohn's Disease</condition>
  <arm_group>
    <arm_group_label>Standard encounter</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard &quot;in-house&quot; clinical visit between patient and physician.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Telemedicine Encounter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Remote clinical appointment between patient and physician.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Collaborative Imaging</intervention_name>
    <description>Hardware and software communication tools to provide clinical care from a distance.</description>
    <arm_group_label>Telemedicine Encounter</arm_group_label>
    <other_name>Telemedicine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (&gt; 18 years old) outpatient IBD patients in the Veterans Affairs medical system

        Exclusion Criteria:

          -  VA patients without IBD

          -  Hospitalized IBD patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tonya Kaltenbach, MD MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Palo Alto Health Care System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Veterans Affairs Palo Alto</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.apple.com/imac/</url>
    <description>telemedicine personal computer</description>
  </link>
  <link>
    <url>http://www.logitech.com/en-us/webcam-communications/webcams/devices/4528</url>
    <description>telemedicine cameras</description>
  </link>
  <link>
    <url>http://www.apple.com/macpro/</url>
    <description>telemedicine personal computer</description>
  </link>
  <link>
    <url>http://www.apple.com/xserve/</url>
    <description>Telemedicine server software</description>
  </link>
  <link>
    <url>http://www.solardigital.com/Site/Home.html</url>
    <description>telemedicine software core</description>
  </link>
  <reference>
    <citation>Telleman H, Burger TF, Mulder CJ. Evolution of gastroenterology training. World J Gastroenterol. 2009 Apr 21;15(15):1793-8.</citation>
    <PMID>19370773</PMID>
  </reference>
  <reference>
    <citation>Fisher ES, Welch HG. The future of the Department of Veterans Affairs health care system. JAMA. 1995 Feb 22;273(8):651-5.</citation>
    <PMID>7844876</PMID>
  </reference>
  <reference>
    <citation>Dorsey ER, Deuel LM, Voss TS, Finnigan K, George BP, Eason S, Miller D, Reminick JI, Appler A, Polanowicz J, Viti L, Smith S, Joseph A, Biglan KM. Increasing access to specialty care: a pilot, randomized controlled trial of telemedicine for Parkinson's disease. Mov Disord. 2010 Aug 15;25(11):1652-9. doi: 10.1002/mds.23145.</citation>
    <PMID>20533449</PMID>
  </reference>
  <reference>
    <citation>Verhoeven F, Tanja-Dijkstra K, Nijland N, Eysenbach G, van Gemert-Pijnen L. Asynchronous and synchronous teleconsultation for diabetes care: a systematic literature review. J Diabetes Sci Technol. 2010 May 1;4(3):666-84. Review.</citation>
    <PMID>20513335</PMID>
  </reference>
  <reference>
    <citation>Grogan-Johnson S, Alvares R, Rowan L, Creaghead N. A pilot study comparing the effectiveness of speech language therapy provided by telemedicine with conventional on-site therapy. J Telemed Telecare. 2010;16(3):134-9. doi: 10.1258/jtt.2009.090608. Epub 2010 Mar 2.</citation>
    <PMID>20197354</PMID>
  </reference>
  <reference>
    <citation>van der Heijden JP, Spuls PI, Voorbraak FP, de Keizer NF, Witkamp L, Bos JD. Tertiary teledermatology: a systematic review. Telemed J E Health. 2010 Jan-Feb;16(1):56-62. doi: 10.1089/tmj.2009.0020. Review.</citation>
    <PMID>20064068</PMID>
  </reference>
  <reference>
    <citation>Wallace P, Haines A, Harrison R, Barber JA, Thompson S, Roberts J, Jacklin PB, Lewis L, Wainwright P; Virtual Outreach Project Group. Design and performance of a multi-centre randomised controlled trial and economic evaluation of joint tele-consultations [ISRCTN54264250]. BMC Fam Pract. 2002 Jan 11;3:1. Epub 2002 Jan 11.</citation>
    <PMID>11835692</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2011</study_first_submitted>
  <study_first_submitted_qc>February 15, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 16, 2011</study_first_posted>
  <results_first_submitted>January 15, 2012</results_first_submitted>
  <results_first_submitted_qc>January 6, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 7, 2013</results_first_posted>
  <last_update_submitted>January 17, 2017</last_update_submitted>
  <last_update_submitted_qc>January 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>VA Palo Alto Health Care System</investigator_affiliation>
    <investigator_full_name>Roy Soetikno</investigator_full_name>
    <investigator_title>Clinical Professor, Chief of Endoscopy</investigator_title>
  </responsible_party>
  <keyword>telemedicine</keyword>
  <keyword>remote consultation</keyword>
  <keyword>telehealth</keyword>
  <keyword>ehealth</keyword>
  <keyword>image archiving</keyword>
  <keyword>inflammatory bowel disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Standard Encounter</title>
          <description>Standard &quot;in-house&quot; clinical visit between patient and physician.</description>
        </group>
        <group group_id="P2">
          <title>Telemedicine Encounter</title>
          <description>Remote clinical appointment between patient and physician.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard Encounter</title>
          <description>Standard &quot;in-house&quot; clinical visit between patient and physician.</description>
        </group>
        <group group_id="B2">
          <title>Telemedicine Encounter</title>
          <description>Remote clinical appointment between patient and physician.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="19"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="34"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58.5" spread="9.6"/>
                    <measurement group_id="B2" value="62.8" spread="11.5"/>
                    <measurement group_id="B3" value="60.4" spread="10.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Patient Clinical Experience</title>
        <description>We used a validated Ware Specific Visit Questionnaire to assess patients’ satisfaction with their clinic-visit encounter. This is a 14-item questionnaire on doctor–patient interaction including factors such as attention to complaints, technical skills, and personal manner (courtesy,and ease of appointment scheduling and is based on a five-point Likert scale (1 excellent to 5 poor). Patients completed the questionnaire at the time of the visit. The 14 item scores were individually scored and then averaged to provide the final overall value.</description>
        <time_frame>Clinic Visit</time_frame>
        <population>per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Telemedicine</title>
            <description>clinic experience (mean ± SD, 1 excellent, 5 poor)</description>
          </group>
          <group group_id="O2">
            <title>Standard</title>
            <description>clinic experience (mean±SD)</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Clinical Experience</title>
          <description>We used a validated Ware Specific Visit Questionnaire to assess patients’ satisfaction with their clinic-visit encounter. This is a 14-item questionnaire on doctor–patient interaction including factors such as attention to complaints, technical skills, and personal manner (courtesy,and ease of appointment scheduling and is based on a five-point Likert scale (1 excellent to 5 poor). Patients completed the questionnaire at the time of the visit. The 14 item scores were individually scored and then averaged to provide the final overall value.</description>
          <population>per protocol</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="0.4"/>
                    <measurement group_id="O2" value="1.3" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 2 sided</method>
            <method_desc>We performed t-test statistics for univariate comparisons for continuous variables.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Clinic Appointment Duration</title>
        <description>The investigators recorded appointment duration in minutes.</description>
        <time_frame>Clinic Visit</time_frame>
        <population>Pilot.</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Encounter</title>
            <description>Standard &quot;in-house&quot; clinical visit between patient and physician.</description>
          </group>
          <group group_id="O2">
            <title>Telemedicine Encounter</title>
            <description>Remote clinical appointment between patient and physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Clinic Appointment Duration</title>
          <description>The investigators recorded appointment duration in minutes.</description>
          <population>Pilot.</population>
          <units>Minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59" spread="18"/>
                    <measurement group_id="O2" value="60" spread="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Clinic Appointment Wait Time</title>
        <description>The investigators recorded clinic appointment wait time duration in minutes</description>
        <time_frame>Clinic Visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Encounter</title>
            <description>Standard &quot;in-house&quot; clinical visit between patient and physician.</description>
          </group>
          <group group_id="O2">
            <title>Telemedicine Encounter</title>
            <description>Remote clinical appointment between patient and physician.</description>
          </group>
        </group_list>
        <measure>
          <title>Clinic Appointment Wait Time</title>
          <description>The investigators recorded clinic appointment wait time duration in minutes</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18" spread="14.5"/>
                    <measurement group_id="O2" value="25" spread="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Standard Encounter</title>
          <description>Standard &quot;in-house&quot; clinical visit between patient and physician.</description>
        </group>
        <group group_id="E2">
          <title>Telemedicine Encounter</title>
          <description>Remote clinical appointment between patient and physician.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Roy Soetikno</name_or_title>
      <organization>VA Palo Alto</organization>
      <phone>650-493-5000 ext 64800</phone>
      <email>soetikno@earthlink.net</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

